ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PRAX Praxis Precision Medicines Inc

54.54
0.38 (0.70%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Praxis Precision Medicines Inc PRAX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.38 0.70% 54.54 16:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
55.40 54.345 55.435 54.54 54.16
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
12/4/202407:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/3/202408:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/3/202406:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:13EDGAR2Form 8-K - Current report
05/3/202406:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202419:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/1/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202416:23EDGAR2Form 8-K - Current report
12/1/202416:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202405:01EDGAR2Form 8-K - Current report
10/1/202416:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202415:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
10/1/202415:10EDGAR2Form 8-K - Current report
09/1/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202316:23EDGAR2Form 8-K - Current report
07/12/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202315:33EDGAR2Form 8-K - Current report
28/11/202306:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
21/11/202315:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
16/11/202307:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
07/11/202306:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:35EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
06/11/202315:24EDGAR2Form 8-K - Current report
02/11/202307:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
16/10/202306:09EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202306:56EDGAR2Form PRE 14A - Other preliminary proxy statements
02/10/202312:27EDGAR2Form 8-K - Current report
02/10/202312:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
27/9/202315:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
19/9/202309:25APSBiotech Catches Major Premarket Bid
07/9/202307:00GLOBEPraxis Precision Medicines to Present at H.C. Wainwright..
31/8/202307:00GLOBEPraxis Precision Medicines to Present Data from Epilepsy..
09/8/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202307:27EDGAR2Form 8-K - Current report
09/8/202306:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
08/8/202306:00GLOBEPraxis Precision Medicines Announces Positive Data from..
07/8/202306:00GLOBEPraxis Precision Medicines Announces Positive Results of EEG..

Su Consulta Reciente

Delayed Upgrade Clock